UBS Group
MDLN icon

UBS Group’s Medline Inc MDLN Stock Holding History

UBS Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$292M Buy
8,426,907
+1,995,894
+31% +$73M 0.04% 464
2026
Q2 		$254M Buy
6,431,013
+3,239,352
+101% +$131M 0.03% 546
2026
Q1 		$142M Buy
3,191,661
+1,889,113
+145% +$83.4M 0.02% 799
2025
Q4 		$54.7M Buy
+1,302,548
New +$55M 0.01% 1522

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

UBS Group's MDLN Position: Q3 2026 in Review

UBS Group increased its Medline Inc (MDLN) stake by 31% in Q3 2026, buying an estimated $73M and bringing the position to 8,426,907 shares worth $292M. The position accounts for 0.04% of the portfolio, ranked #464.

UBS Group first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • UBS Group held 8,426,907 shares of Medline Inc worth $292M as of Q3 2026.
  • UBS Group bought 1,995,894 Medline Inc shares in Q3 2026, an estimated $73M.
  • Medline Inc made up 0.04% of UBS Group's portfolio in Q3 2026, its #464 holding.
  • UBS Group first reported a position in Medline Inc in Q4 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.